ArticleVirus genes2003
The 113th and 117th charged amino acids in the 5th alpha-helix of the HBV core protein are necessary for pgRNA encapsidation.
Article in Virus genes, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 5 citations in OpenAlex.
- The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely.Scientific reports · 2016Article
- Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids.Journal of virology · 2013Article
- A SELEX-screened aptamer of human hepatitis B virus RNA encapsidation signal suppresses viral replication.PloS one · 2011Article
- Testing the balanced electrostatic interaction hypothesis of hepatitis B virus DNA synthesis by using an in vivo charge rebalance approach.Journal of virology · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although the structure-function of hepatitis B virus (HBV) core protein has been investigated by numerous HBV core mutants, functions of many regions in the core protein are still remained to be identified. In this report, it was found that point mutations in the 113th and 117th negative-charged amino acids in the 5th helix region of the HBV core strongly affect pregenomic RNA (pgRNA) encapsidation. These mutations were introduced by site-directed mutagenesis. The following results were obtained from analyses of the mutants. First, endogenous polymerase activity (EPA) was assayed and activity was not detected only in the two mutants, E113K and E117K. Second, the pgRNA encapsidation level of each mutant related to a change in charge of two amino acid sites was evaluated. Mutations in the 113th and 117th amino acids into uncharged amino acids reduced pgRNA encapsidation levels. Moreover, changes of the two amino acids into positive-charged amino acids almost completely reduced pgRNA encapsidation levels. To test whether the mutant core proteins assembled into normal capsid particles, the assembly of the mutant core proteins was seen. However, none of the changes in the 113th and 117th amino acids affected capsid formation. From this data, it can be inferred that the above two amino acids in the 5th alpha-helix in the HBV core protein are important for pgRNA encapsidation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.